Early enteral nutrition in critically ill patients with a high-protein diet enriched with arginine, fiber, and antioxidants compared with a standard high-protein diet.: The effect on nosocomial infections and outcome

被引:79
作者
Caparrós, T
Lopez, J
Grau, T
机构
[1] Fdn Jimenez Diaz, Intens Care Unit, E-28040 Madrid, Spain
[2] Hosp Severo Ochoa, Leganes, Spain
[3] Hosp Univ Getafe, Madrid, Spain
关键词
D O I
10.1177/0148607101025006299
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: This study was designed to evaluate the effects of a high-protein formula enriched with arginine, fiber, and antioxidants compared with a standard high-protein formula in early enteral nutrition in critically ill patients. Methods: For this study, 220 patients were enrolled in a prospective, multicenter, single-blind, randomized trial in 15 Spanish intensive care units (ICUs). The primary endpoints were the incidence density rates of nosocomial infections, ICU and hospital length of stay, ICU and in-hospital mortality, and mortality at 6-month follow-up. Results: The patients in the control and study groups had similar baseline characteristics. The study group had a lower incidence of catheter-related sepsis (0.4 episodes/1000 ICU days) than the control group (5.5 episodes/1000 ICU days), with a relative risk (RR) of 0.07 (95% confidence interval [CI] 0.01 to 0.54, P < .001). There were no differences in the incidence of ventilator-associated pneumonia, surgical infection, bacteremia, or urinary tract infections between the 2 groups. ICU mortality (16% in the study group versus 21% in the control group; RR 1.5, Cl 95% 0.7 to 2.9) and in-hospital mortality (21% in the study group versus 30% in the control group; RR 1.6, CI 95% 0.9 to 3) were similar without differences in survival at 6-month follow-up (75% in the study group versus 68% in the control group, p = .15). Patients in the study group who were treated for 2 or more days showed a strong trend for better survival at 6-month follow-up (76% in the study group versus 67% in the control group, p = .06). Medical patients treated with the study diet had better survival than medical patients in the control group (76% in the study group versus 59% in the control group, p < .05). Conclusions: Critically ill patients fed a high-protein diet enriched with arginine, fiber, and antioxidants had a significantly lower catheter-related sepsis rate than patients fed a standard high-protein diet. There were no differences in mortality or ICU and hospital length of stay. The subgroup of patients fed the study diet for >2 days showed a trend toward decreased mortality.
引用
收藏
页码:299 / 309
页数:11
相关论文
共 55 条
[1]   Effects of a partially hydrolyzed guar gum on intestinal absorption of carbohydrate, protein and fat: a double-blind controlled study in volunteers [J].
Alam, NH ;
Meier, R ;
Rausch, T ;
Meyer-Wyss, B ;
Hildebrand, P ;
Schneider, H ;
Bachmann, C ;
Minder, E ;
Fowler, B ;
Gyr, K .
CLINICAL NUTRITION, 1998, 17 (03) :125-129
[2]   Diets and infection: Composition and consequences [J].
Alexander, JW ;
Ogle, CK ;
Nelson, JL .
WORLD JOURNAL OF SURGERY, 1998, 22 (02) :209-212
[3]   A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill [J].
Atkinson, S ;
Sieffert, E ;
Bihari, D .
CRITICAL CARE MEDICINE, 1998, 26 (07) :1164-1172
[4]   Immunonutrition in the critically ill: A systematic review of clinical outcome [J].
Beale, RJ ;
Bryg, DJ ;
Bihari, DJ .
CRITICAL CARE MEDICINE, 1999, 27 (12) :2799-2805
[5]  
BELL SJ, 1991, J AM DIET ASSOC, V91, P74
[6]   AMERICAN-COLLEGE OF CHEST PHYSICIANS SOCIETY OF CRITICAL CARE MEDICINE CONSENSUS CONFERENCE - DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ ;
ABRAMS, JH ;
BERNARD, GR ;
BIONDI, JW ;
CALVIN, JE ;
DEMLING, R ;
FAHEY, PJ ;
FISHER, CJ ;
FRANKLIN, C ;
GORELICK, KJ ;
KELLEY, MA ;
MAKI, DG ;
MARSHALL, JC ;
MERRILL, WW ;
PRIBBLE, JP ;
RACKOW, EC ;
RODELL, TC ;
SHEAGREN, JN ;
SILVER, M ;
SPRUNG, CL ;
STRAUBE, RC ;
TOBIN, MJ ;
TRENHOLME, GM ;
WAGNER, DP ;
WEBB, CD ;
WHERRY, JC ;
WIEDEMANN, HP ;
WORTEL, CH .
CRITICAL CARE MEDICINE, 1992, 20 (06) :864-874
[7]   EARLY ENTERAL ADMINISTRATION OF A FORMULA (IMPACT((R))) SUPPLEMENTED WITH ARGININE, NUCLEOTIDES, AND FISH-OIL IN INTENSIVE-CARE UNIT PATIENTS - RESULTS OF A MULTICENTER, PROSPECTIVE, RANDOMIZED, CLINICAL-TRIAL [J].
BOWER, RH ;
CERRA, FB ;
BERSHADSKY, B ;
LICARI, JJ ;
HOYT, DB ;
JENSEN, GL ;
VANBUREN, CT ;
ROTHKOPF, MM ;
DALY, JM ;
ADELSBERG, BR .
CRITICAL CARE MEDICINE, 1995, 23 (03) :436-449
[8]  
Braga M, 1996, ARCH SURG-CHICAGO, V131, P1257
[9]  
BRAGA M, 1995, INFUSIONSTHERAPIE, V22, P280
[10]   Recent developments in lipid emulsions: Relevance to intensive care [J].
Carpentier, YA ;
Simoens, C ;
Siderova, V ;
ElNakadi, I ;
Vanweyenberg, V ;
Eggerickx, D ;
Deckelbaum, RJ .
NUTRITION, 1997, 13 (09) :S73-S78